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Abstract
The objectives of this article are to systematically review i) the extent of medicine use in postpartum women, and ii)
the impact of maternal medicine use (excluding contraceptives and galactogogues) on breastfeeding outcomes
(initiation and/or duration). PubMed, Medline (Ovid), Scopus (Elsevier), Cinahl (EBSCO), PsycINFO (Ovid), Embase (Ovid)
and Web of Science (ISI) databases were searched to find original studies on medicine use in women after the birth.
Additional studies were identified by searching Google Scholar, Wiley Online Library, Springer Link, selected journals
and from the reference list of retrieved articles. Observational studies with information about postpartum women’s use
of any type of medicine either for chronic or acute illnesses with or without breastfeeding information were included.
The majority of relevant studies suggest that more than 50 % of postpartum women (breastfeeding or not) required at
least one medicine. Due to the lack of uniform medication use reporting system and differences in study designs,
settings and samples, the proportion of medicine use by postpartum women varies widely, from 34 to 100 %.
Regarding the impact of postpartum women’s medicine use on breastfeeding, a few studies suggest that women’s use
of certain medicines (e.g. antiepileptics, propylthiouracil, antibiotics) during lactation can reduce initiation and/ or
duration of breastfeeding. These studies are limited by small sample size, and with one exception, all were conducted
in Canada more than a decade ago. Large scale studies are required to establish the relationship between maternal
medicine use and breastfeeding, considering type of illness, period of use and total duration of medicine use.
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Introduction
During the postpartum period, many women face acute
and chronic health problems such as cough/colds, infec-
tions, bowel problems, mastitis, headache, back pain,
migraine, hypertension, depression [1–7], and need to take
medication. Fortunately, most commonly used medicines
are considered safe during lactation and adverse effects of
maternal medicine use on breastfed infants are rare or
minimal [8–10]. The need to take medicine, however, is
one of women’s self-reported reasons for discontinuation
of breastfeeding [2, 11, 12].
In addition, many health professionals lack evidence-
based knowledge and may advise women to stop breast-
feeding while taking medicines [13–17]. A critical
review of health professionals’ knowledge, attitudes and
practices towards medicine use in breastfeeding women
has highlighted this issue [18].
An USA study about health professionals’ knowledge
of women’s issues and epilepsy showed that more than
50 % of health professionals did not know that women
taking most antiepileptics could breastfeed safely [19]. In
addition, a study conducted in Puerto Rico revealed that
39 % of physicians thought breastfeeding should be
contraindicated for women using antidepressants [20].
Australian studies have shown that about one third of
general practitioners and community pharmacists were
not aware that ibuprofen is compatible with breastfeeding
[21, 22].
In addition, the reliability of safety information for com-
monly used medicines in information databases (e.g. the
Physicians’ Desk Reference) is not always accurate [23],
which results in many women being inappropriately
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advised to stop breastfeeding. Moreover, studies in breast-
feeding women and their infants are rarely conducted and
clinical risk assessment for many drugs required by breast-
feeding women is often compromised due to lack of data
[24].
Despite breastfeeding being actively promoted, the issue
of women’s use of medicines has not received much atten-
tion [25]. The extent of maternal use of medicine during
the postpartum period has not been reviewed thoroughly
and the impact of postpartum maternal medicine on initi-
ation and duration of breastfeeding is not established.
Therefore, the objectives of this paper are to systematically
review the literature about the extent of medicine use in
postpartum women, and evaluate whether or not there is
a negative impact of maternal medicine use postpartum
on breastfeeding outcomes especially on initiation and /or
duration of breastfeeding.
Review
Selection criteria of articles
Inclusion criteria
Any English language full reports of original studies about
medicine use for acute or chronic illnesses in postpartum
women with or without breastfeeding information. Arti-
cles in languages other than English meeting the above
criteria were also selected.
Exclusion criteria
Studies based on contraceptives and galactogogues use
only were excluded because of their potential to modu-
late maternal milk supply and are not the subject of
our review.
Literature search, study selection and screening process
We conducted the primary literature search in PubMed,
Medline (Ovid), Scopus (Elsevier), Cinahl (EBSCO),
PsycINFO (Ovid), Embase (Ovid) and Web of Science
(ISI) databases using ‘medications’, ‘medicines’, ‘drug
therapy’ ‘maternal’, ‘women’, ‘mothers’, ‘postpartum’,
‘postnatal’, lactation’ and ‘breastfeeding’ as search
terms in different combinations since the start of each
database. No specific limitation was applied while
searching. The literature search was conducted in No-
vember 2012 to March 2013. An update of the search
was conducted in August 2015.
We conducted a secondary literature search in Google
Scholar, Wiley Online Library, Springer Link and se-
lected journals (Pediatrics, Pharmacoepidemiology and
Drug Safety, Breastfeeding Medicine, Journal of Human
Lactation and International Breastfeeding Journal) to
find relevant article titles using some selected thera-
peutic group names or selected medicine names and
breastfeeding as key words. The name of therapeutic
groups included in the search were ‘antidepressants or
SSRIs or selective serotonin reuptake inhibitors’, ‘antipsy-
chotics’, ‘antihypertensives’, ‘antiasthmatics’, ‘thyroid medi-
cations’, ‘antimigraine medications’ and ‘antiepileptics’.
Selected medicines used in the search were ‘paroxetine’,
‘sertraline’, ‘citalopram’, ‘escitalopram’ and ‘fluoxetine’. The
objective of using these selective therapeutic groups or
medicines in the search was to find any studies about
these specific groups or medicines which were not identi-
fied in the primary search. The reference lists of retrieved
articles were also checked and previously unidentified
studies located whenever possible.
After removal of duplicates, irrelevant articles were
eliminated by screening the titles and/or abstracts. Then
the potential full text articles were assessed for eligibility
against selection criteria described earlier. MRS con-
ducted the literature search and screened the articles in
consultation with KR and LHA.
Quality assessment of the articles
The selected full text research articles were studied thor-
oughly and the quality of each eligible article was
assessed independently by MRS and LHA using the
checklist adopted by Macfarlane et al. [26] designed
from Downs and Black [27] and Crombie [28]. The
checklist contained 8 items for abstracts and 20 items
for full articles for cross-sectional studies or 22 items for
cohort studies (Additional file 1). Each item in the
checklist was scored as ‘yes’, ‘no’ or unable to determine
where there was insufficient or unclear information.
Each positively scored criterion was added for both
abstract and full-text article separately to obtain a total
quality score, expressed as a percentage, per study (add-
ing the number of ‘yes’ per item; abstract and paper: 22
items for cohort study, and 20 items for cross-sectional
study). The average score per item in the checklist for
the total number of studies was also calculated adding
the number of ‘yes’ per item and was expressed as a
percentage. Multiple articles reporting the same study
were assessed separately and an average score was
reported for that study.
In addition, the quality of eligible cohort studies
reporting the impact of maternal medicine use on
breastfeeding was assessed using the Newcastle-Ottawa
quality assessment scale [29] in which a study can be
awarded a total of 9 stars for 8 items: 4 items for ‘selec-
tion’, 1 item for ‘comparability’ and 3 items for ‘outcome’
(Additional file 2). A maximum of one star can be given
for each numbered item within the ‘selection’ and ‘out-
come’ categories and maximum of two stars for ‘compar-
ability’. Any disagreements about the methodological
quality of the articles were resolved in a discussion be-
tween team members. In addition, weakness and bias of
the studies were also noted.
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Data extraction
First, we divided all the included articles into two
groups: i) studies which were focused on different types
of medicine use with or without information about breast-
feeding practices and ii) studies which analysed the impact
of medicine use (group or specific) on breastfeeding statis-
tically. Then, we extracted the data in tabular form which
included author, publication year, country of study, study
type, outcome measures, most frequently used medicines,
breastfeeding information and findings of statistical ana-
lyses, quality assessment score and limitation(s). MRS syn-
thesized the data which was also checked by LHA for
accuracy. During data synthesis two primary outcome
measures were abstracted: 1) extent of medicine use in
postpartum women which was defined as the proportion
(%) of women (breastfeeding or not) using one or more
medicines and 2) impact of postpartum women’s use of
medicine (any group or specific) on initiation and/or
duration of breastfeeding. We also abstracted three sec-
ondary outcomes where available: 1) most frequently used
medicines by postpartum women, 2) comparison of types
of medicine used by postpartum women in different coun-
tries according to the Anatomical Therapeutic Chemical
(ATC) classification system developed by the World Health
Organization (WHO) which is recognized as the inter-
national language and gold standard for drug utilization
research and 3) women’s concerns, behaviour and decision-
making about use of medicines while breastfeeding. We
summarized the findings in tables according to the chrono-
logical order of publication year of the articles.
Results
Study selection
Figure 1 illustrates the study selection process using a
PRISMA flow diagram [30].
From the primary literature searches we found 1807
citations. First, we removed 390 duplicate citations and
then 1341 were removed after checking the titles and/or
abstracts leaving 76 relevant articles. Our secondary
literature searches and checking the reference lists of
retrieved articles resulted in additional 9 relevant articles
for screening. Thus we screened 85 articles for eligibility
assessment. Review articles were eliminated (n = 60; 25
about safety and compatibility of psychotropic medicines
while breastfeeding, and 35 other topics like oral contra-
ceptive use and breastfeeding and others). Finally, 25
full-text articles [31–55] (24 English and 1 Portuguese
[42]) were assessed for eligibility for inclusion. Five fur-
ther articles were excluded: one article based on impact
of antidepressant use during pregnancy on breastfeeding
[32]; two articles did not contain overall medicine use
information [31, 40]; one article [35] contained informa-
tion about maternal use of self-medication only and was
based on the same cohort used in another article [33]
included in this review; and another one [54] was a letter
to the editor. Two articles [45, 46] using the same cohort
were considered as a single study and two articles [41, 44]
from the same survey were also abstracted as one study.
Thus, a total of 20 articles [33, 34, 36–39, 41–53, 55] con-
sisting of 18 studies were included in the review. The up-
date of the literature search in August 2015 did not
identify any new primary studies for inclusion.
Study details
Of the 18 selected studies, 10 consisting of 11 articles
[33, 34, 36–38, 43, 45–48, 51] were cohort studies and 8
consisting of 9 articles [39, 41, 42, 44, 49, 50, 52, 53, 55]
were cross-sectional in design. The studies are summa-
rized in Tables 1 and 2.
The studies were published between 1984 and 2011, and
were conducted between 1982 and 2007. With the excep-
tion of 2 studies in India and 2 in Brazil, most studies were
conducted in developed countries: 4 in Canada, 2 in the
Netherlands, 2 in Norway, 2 in Sweden, 1 in Denmark, 1
in the UK, 1 in Ireland and 1 in the USA.
Excepting the large register-based pharmacoepide-
miological studies or articles [34, 36, 38, 45, 46] (n =
5412 to 106,329), the sample size of most studies was
small to medium (n = < 100 to ˂ 1000).
Quality assessment
Macfarlane’s checklist score
Tables 1 and 2 show the quality scores of the 18 studies
evaluated. There was a large variation in quality be-
tween the abstracts and full articles of the individual
studies. Overall, the quality score for the abstracts
ranged from 38 to 100 %, and for the full-text articles
from 60 to 86 %.
Newcastle-Ottawa quality assessment score
Five cohort studies with information about the impact of
maternal use of medicine on breastfeeding outcomes
were eligible for assessment using the Newcastle-Ottawa
quality assessment scale (Table 2). The scores ranged
between 6 and 8 stars (maximum = 9 stars).
Extent of medicine use in postpartum women and most
frequently used medicines
Sixteen reports [33, 34, 36–39, 41, 42, 44–46, 49, 50,
52, 53, 55] based on 14 studies had information about
different types of medicines used by women during
lactation or the postpartum period, but these studies
either did not have breastfeeding information or did
not analyze the impact of maternal medicine use on
breastfeeding outcomes statistically except for one
[33]. Table 1 summarizes the extent and type of med-
icines used by postpartum women.
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All of these studies, except one [46] suggested that
more than 50 % of women required medicine during the
postpartum period. However, hospital based studies indi-
cated that the maximum extent of medicine use in
women during the postpartum period could be up to
100 % if vitamins/minerals are included [49], while large
register-based pharmacoepidemiological studies reported
maximum use up to 57 % [36] without any breastfeeding
information.
The most commonly used medicines in register-
based studies were systemic antibacterials, if sex hor-
mones (e.g. oral contraceptive) were not considered.
In the rest of the studies, analgesics/antipyretics, non-
steroidal anti-inflammatory drugs (NSAIDs) and anti-
bacterials/antibiotics were the most commonly used
medicines if vitamins, minerals, or iron preparations
were not considered.
Comparison of types of medicine used by postpartum
women in different countries according to ATC
classification system
Large pharmacoepidemiological articles [34, 36, 38, 45, 46]
and one survey [52] used the ATC classification system to
report medicine use in women during the postpartum
period. Systemic antibacterials (ATC code J01) were
commonly used short-term medicines according to in-
formation available in large pharmacoepidemiological
studies conducted in Sweden [34], Norway [36], the
Netherlands [38] and Denmark [46] ranging between
13 and 16 % of medicines used (Table 1). Table 3 de-
picts the proportion of postpartum women who used
medicines for different chronic diseases in Sweden,
Norway and the Netherlands.
The impact of postpartum use of maternal medicine on
breastfeeding outcomes
Five studies [33, 43, 47, 48, 51] analysed the impact of
maternal medicine (group/specific medicine) on breast-
feeding (Table 2). One study by Chaves et al. from Brazil
[33] showed the relationship between maternal use of
medicines and duration of breastfeeding classifying med-
icines according to Hale’s Medications and Mothers’
Milk 2004 [56] and by the American Academy of
Pediatrics 2001 publication on ‘Transfer of drugs and
other chemicals into human milk’ [17]. The authors
concluded that women using unclassified drugs according
to Hale’s criteria were most likely to cease breastfeeding
compared to women using breastfeeding compatible
Fig. 1 Steps of study selection process using a PRISMA flow diagram [30]
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Table 1 Extent of medicine use in women during postpartum period or lactation
Author and
publication
year
Country, study type, sample, design and
settings
Postpartum/
lactation
period
Proportion of women
using ≥ 1 medicine during
lactation and frequently used
medicines
Macfarlane’s quality score, and
limitation(s)
Chaves et al.,
2011 [33]
Brazil, cohort study, n = 246 12 months 98 % Quality score: Abstract: 88 %, Paper: 77 %
Pregnant women were recruited
between June and Sept 2003. Nursing
mothers were followed up after hospital
discharge by telephone contact or
home visits up to 12 months
postpartum or until breastfeeding
ceased.
Analgesics/antipyretics 24.7 %
Iron salts 13.7 % Limitation(s): Commonly used medicines
were reported as % of total number of
prescriptions. ATC classification was not
used.
NSAIDs 12.8 %
(% based on total number of
prescriptions)
Stephansson
et al., 2011
[34]
Sweden, cohort study, n = 102,995 3 months 51 % Quality score: Abstract: 75 %, Paper: 64 %
Women using prescription medicines
during pregnancy and 3 months
postpartum in 2007, collected from
Swedish Medical Birth Register and the
Prescribed Drug Register.
Sex hormones 21.91 %
Systemic antibacterials
13.77 %
Limitation(s): Actual drug intake bias as
data source was register. No
breastfeeding information was available
NSAIDs 7.06 %
Engeland et
al., 2008 [36]
Norway, cohort study, n = 106,329 3 months 57 % Quality score: Abstract: 75 %, Paper: 64 %
Women using prescription medicine
during pregnancy and 3 months
postpartum, collected from Medical
Birth Registry of Norway and Norwegian
Prescription Database of 2004–2006.
Sex hormones 26.7 %
Systemic antibacterials 16 % Limitation(s): Actual drug intake bias as
data source was register. No
breastfeeding information was availablePosterior pituitary lobe
hormones 8 %
Dermatologicals 6.9 %
Stultz et al.,
2007 [37]
USA, cohort study, n = 45 breastfeeding
women
12 months 96 % Quality score: Abstract: 50 %, Paper: 77 %
Women after delivery filled out a
prenatal questionnaire and were
followed up monthly by telephone for
12 months postpartum or until
cessation of breastfeeding or until the
close of the study in Jan 2007. They
were also instructed to keep a diary
regarding use of medicine.
Vitamins 73 %
NSAIDs 71 % Limitation(s): Very small study. ATC
classification was not used. Detail
breastfeeding information was not
available. The impact of medicine use
on breastfeeding was not studied.
Acetaminophen 58 %
Progestins 24 %
Antimicrobials 22 %
Bakker et al.,
2006 [38]
Netherlands, cohort study, n = 5.412
postpartum women
3 months 68 % Quality score: Abstract: 88 %, Paper: 68 %
Pharmacy records of women giving
birth between 1994 and 2003 were
collected from the InterAction database
which contains prescription drug
information from community
pharmacies.
Iron preparations 30.4 %
Systemic antibacterials 13.3 % Limitation(s): Actual drug intake bias as
data source was register. No
breastfeeding information was availableLaxatives 6.9 %
NSAIDs 5 %
Schirm et al.,
2004 [39]
Netherlands, cross-sectional study, n =
549
<6 months 66 % of 451 breastfeeding
women
Quality score: Abstract: 88 %, Paper: 70 %
Questionnaires were handed out to
women with a child < 6 months
through 85 Well-Baby Clinics over a
6 week period in 2002. 549 women
responded and 451 of them breastfed
and 297 of them used medicine.
Vitamins 40.8 %
Oral analgesics 36.8 % Limitation(s): ATC classification was not
used . The impact of medicine use on
breastfeeding was not studied
statistically.
Antiinfectives 14.6 %
Gastrointestinal drugs 6.9 %
Lamounier et
al., 2003 [42]
Brazil, cross-sectional study, n = 2,173 Immediate
postpartum
period
96 % Quality score: Abstract: 75 %, Paper: 60 %
2,173 women giving birth in four
hospitals of Belo Horizonte city in Brazil
between July 1998 and July 1999 were
interviewed using questionnaire.
Medical records were also checked.
Anti-inflammatory 77.8 %
Analgesics 75.5 % Limitation(s): ATC classification was not
used. Detail breastfeeding information was
not available. The impact of medicine use
on breastfeeding was not studied.
Antibiotics 17.8 %
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Table 1 Extent of medicine use in women during postpartum period or lactation (Continued)
Jones and
Brown 2003
[41] & 2000
[44]
UK, cross-sectional study, n = 820 Within 5 days
after delivery
and after
hospital
discharge
56.5 % within 5 days after
delivery
Quality score: Abstract : 38 %, Paper: 85 %
Questionnaires were sent to postpartum
women, in southern England between
March and April 1995 and 820
breastfeeding women responded.
55 % after hospital discharge
Antibiotics 14.27 % Limitation(s): ATC classification was not
used. The impact of medicine use on
breastfeeding was not studied.Analgesics 3.3 %
Olesen et al.
1999 [45, 46]
Denmark, cohort study, n = 15,756 to
16,001
12 weeks 34.2 % to 34.7 % Quality score: Abstract: 88 %; Paper: 64 %
Information about women’s prescription
drug use during pregnancy and
12 weeks postpartum was collected
from North Jutland Prescription
Database from 1 Jan 1991 to 31 Dec
1996 and linked to Danish Medical Birth
Register.
Penicillins 20.1 %
Opthalmologicals 15.5 % Limitation(s): Actual drug intake bias as
data source was register. No
breastfeeding information was availableDermatological
corticosteroids 5.7 %
(% based on total number of
prescriptions)
Thomas et
al., 1994 [49]
India, cross-sectional study, n = 539 6 weeks 100 % Quality score: Abstract: 38 %, Paper: 70 %
Women who gave birth at a Southern
Indian Hospital between June and Sept
1989, were interviewed using a
questionnaire from the day of discharge
to 6 weeks postpartum during their
subsequent visits in hospital. Hospital
charts were also reviewed.
Vitamins and minerals 100 %
Antipyretics 53.1 % Limitation(s): ATC classification was not
used. The impact of medicine use on
breastfeeding was not studied.Anti-inflammatory 49.2 %
Antibiotics 37.8 %
Uppal et al.,
1993 [50]
India, cross-sectional study, n = 500 N/A 90 % Quality score: Abstract: 63 %, Paper: 75 %
200 women giving birth in Nehru
Hospital, 200 attending the postpartum
clinic at the same hospital, and 100
women living in a rural area were
interviewed between Nov 1989 and
May 1990. Hospital records were also
checked.
For hospital, postpartum
clinic and community
settings-
Antibiotics: 90 %, 86 % and
13 % respectively
Limitation(s): ATC classification was not
used. The impact of medicine use on
breastfeeding was not studied. Very little
breastfeeding information.Analgesics: 56 %, 70 % and
37.6 % respectively
Blomquist
and
Soderman,
1991[52]
Sweden, cross-sectional study, n = 195 Up to
4 months
70 % (excluding vitamins) Quality score: Abstract: 75 %, Paper: 65 %
Women giving birth between 12 Jan
and 8 Feb 1987 were asked to answer a
questionnaire after hospital discharge.
195/229 women responded.
Vitamins 45 %
Pituitary hormones 29 % Limitation(s): The impact of medicine
use on breastfeeding was not studied.
Very little breastfeeding informationSex hormones 18 %
Matheson et
al., 1990 [53]
Norway, retrospective survey, n = 885 3–5 months 69 % Quality score: Abstract: 63 %, Paper: 70 %
Women 3–5 months after delivery
responded to a postal questionnaire in
1985.
Analgesics/antipyretics 32 %
Dermatologicals 19 % Limitation(s): ATC classification was not
used. The impact of medicine use on
breastfeeding was not studied.Antihaemorrhoidals 15 %
Passmore et
al., 1984 [55]
Ireland, cross-sectional study, n = 2,004 Immediate
postpartum
period
99 % Quality score: Abstract: 75 %, Paper: 65 %
Medicine charts of women giving birth
in three hospitals of Belfast between
July to Sept 1982.
Analgesics 78.4 %
Antibacterials 15.5 % Limitation(s): ATC classification was not
used. Very little breastfeeding
information.Hypnotics 36 %
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drugs. A study by Lee et al. (2004) showed that the major-
ity of women (57 %) receiving propylthiouracil (a medicine
for hyperthyroidism) did not initiate breastfeeding [43]
and a study by Ito (1999) indicated that a significant pro-
portion of women (32 %) taking a medicine of concern
terminated breastfeeding earlier than women not tak-
ing a medicine of concern (p < 0.04) [47]. Ito et al.
(1995) in an earlier study of antiepileptics also showed
that women receiving antiepileptic medicines had both
lower initiation and duration of breastfeeding com-
pared to women receiving no antiepileptics postpar-
tum [48]. In addition, Ito et al. (1993) in a study of
antibiotics showed that 7 % of women stopped breast-
feeding during antibiotic therapy [51].
Table 2 Impact of maternal medicines on breastfeeding
Author and publication
year
Country, study type, sample,
design and settings
Results Quality score and limitation(s)
Chaves et al., 2011 [33] Brazil, cohort study, n = 246 Duration of breastfeeding was
longer in women who used no
medicine or who used medicines
compatible with breastfeeding
(p< 0.05).
Macfarlane’s checklist: See Table 1
Other information is available
in Table 1.
Newcastle-Ottawa: 8/9 (Selection: 4*,
Comparability:2*, Outcome: 2*)
Limitation(s): See Table 1
Lee et al., 2000 [43] Canada, cohort study, n = 36
(exposure group)
44 % of women receiving PTU
initiated breastfeeding compared
to 83 % in the two control groups
(Group 1 vs Group 2, p< 0.01; group
1 vs group 3, p< 0.01).
Macfarlane’s checklist: Abstract: 88 %,
Paper: 73 %
Women requiring propylthiouraci
l (PTU) during pregnancy
(Jan 1990 to Sept 1997) were
recruited and interviewed
postpartum regarding their
choice of infant feeding method.
36 women required PTU
postpartum (Group 1); 30 did
not (Group 2); 36 healthy women
were controls (Group 3).
Newcastle-Ottawa: 8/9 (Selection: 4*,
Comparability: 2*, Outcome: 2*)
Limitation(s): Study is based on
selective medicine
Ito, 1999 [47] Canada, cohort study, n = 88 69 women used medicines
(Group 1) and 19 women did
not start the medicine of concern
(Group 2). 22 (32 %) of Group 1
women stopped breastfeeding
before the infant was 6 months
old while 1 (5 %) of the Group 2
women did so (p < 0.04).
Macfarlane’s checklist: Abstract: 88 %,
Paper: 82 %
Breastfeeding women who
received reassuring advice
about compatibility of medicine
from the Motherisk Teratogen
Information Center in Toronto
about their medicines in 1993
were followed up by interview
up to cessation of breastfeeding
or until the infant reached to
7 months.
Newcastle-Ottawa: 7/9 (Selection: 4*,
Comparability: 1*Outcome: 2*)
Limitation(s): Small sample size
Ito et al., 1995 [48] Canada, cohort study, n = 34
(exposure group)
50 % of women receiving medicines
started breastfeeding compared to
85 % in control group (p= 0.004).
Median duration of breastfeeding
in medicine group was significantly
shorter than that in control group
(4.7 ± 2.6 vs 9.3 ± 5.7 months, p< 0.005).
65 % of women (11/17) taking antiepileptics
stopped breastfeeding within 6
months whereas in control group,
only 21 % of women (6/29) did so (p< 0.008).
Macfarlane’s checklist: Abstract: 88 %,
Paper: 86 %
Women receiving antiepileptics
during pregnancy were
interviewed between April and
June, 1993, by the Motherisk
Teratogen Information Center
in Toronto. 34 pregnant
age-matched women were controls.
Newcastle-Ottawa: 7/9 (Selection: 4*,
Comparability: 1*, Outcome: 2*)
Limitation(s): Study is based on
selective medicine
Ito et al., 1993 [51] Canada, prospective cohort study,
n = 203
125 women were followed
within 32 weeks of the initial
consultation. 106 women started
antibiotic therapy and 7 % of
them stopped breastfeeding
during therapy.
Macfarlane’s checklist: Abstract: 100 %,
Paper: 64 %
Breastfeeding women who
consulted the Motherisk
Teratogen Information Center
in Toronto between Jan 1990
and Jul 1991 about the compatability
of antibiotics with breastfeeding after
receiving antibiotic prescriptions.
Newcastle-Ottawa: 6/9 (Selection: 4*,
Comparability: 1*, Outcome: 1*)
Limitation(s): Study is based on
selective medicine, small sample and
has attrition bias
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Women’s concerns, behaviour and decision-making about
use of medicines while breastfeeding
Many women hesitate to combine medicine use with
breastfeeding, or do not initiate breastfeeding, or stop
taking medicines while breastfeeding, or quit breastfeed-
ing, or chose formula feeding while taking medicines
[39, 43, 47, 48, 51] (Table 4). One study found that many
women were more doubtful about medicine use during
lactation than during pregnancy [53].
Critical findings
This systematic review summarizes the methodological
quality, design and findings of eighteen observational
studies about postpartum women’s use of medicines with
or without breastfeeding information. Findings suggest
that medicine use in postpartum women is very com-
mon, but due to differences in study design, inconsistent
reporting and large variations in sample sizes (n = < 100
to 106,329), the prevalence of medicine use by postpar-
tum women in different countries are not comparable.
Moreover, all large pharmacoepidemiological, register-
based studies or articles [34, 36, 38, 45, 46] were limited
by lack of breastfeeding information and may be biased
as registers do not contain information about whether
or not individuals actually used the medicine. In
addition, these studies were mainly focused on medicine
Table 3 Proportion of women using medicines for various
chronic diseases in the first three months postpartum
Medication group Proportion of women (%)
Sweden [34]
n = 102,995
Norway [36]
n = 106,329
Netherlands [38]
n = 5,412
Cardiovascular drugs (C) 3.06 4.9 N/A
Thyroid therapy (H03) 1.81 1.4 1.0
Antiasthmatics (R03) 1.51 1.3 2.1
Antidepressants (N06A) 1.6 0.7 2.1a
Drugs for diabetes (A10) 0.4 0.3 0.4
Antiepileptics (N03) 0.3 0.3 0.3
aAntidepressants including antipsychotics (N05A)
Table 4 Women’s concerns and behaviour towards use of medicines while breastfeeding
Authors and year of publication Women’s concerns and behaviour towards use of medicines
while breastfeeding
Schirm et al., 2004, Netherlands [39] 297 women used medicine. 30 % of them hesitated to take
a medicine while breastfeeding. Almost 10 % of 297 women
(breastfeeding yes, medicine yes) stopped either breastfeeding
or medicine use. 17 % of 154 women (breastfeeding yes,
medicine no) indicated they would have used medicine if they
were not breastfeeding. About 12 % of 78 women (breastfeeding
no, medicine yes) mentioned medicine use as the reason
for not breastfeeding.
A cross-sectional survey of postpartum women about their
medicine use and breastfeeding
n = 549
Lee et al., 2000, Canada [43] 60 % of 20 formula feeding women mentioned that physicians’
advice or their concern about the medicine was the primary
reason for not breastfeeding. Women given advice by their
physician in favor of breastfeeding were more likely to
breastfeed than women not given this advice (Relative Risk:
5.48; 95 % CI: 1.28–23.40).
A cohort study of women requiring propylthiouracil
n = 36 (exposure group)
Ito, 1999, Canada [47] 19 women (22 %) did not start the medicine of concern while
breastfeeding despite their need for medicine.
A cohort study of medicine use in breastfeeding women
who had concern for their medicines
n = 88
Ito et al., 1995, Canada [48] 50 % (17/34) of women did not initiate breastfeeding and chose
to formula feed and 88 % of them mentioned medicine was the
reason of formula feeding.A cohort study of antiepileptics
n = 34 (exposure group)
Ito et al., 1993, Canada [51] 125 (62 %) women were followed within 32 weeks. 19 (15 %)
women did not initiate the antibiotic therapy. 21 % women
either did not start the required medicine or stopped
breastfeeding while taking medicine.
A cohort study of antibiotic use and breastfeeding
n = 203
Matheson et al., 1990, Norway [53] 17 % women showed more doubts about medicine use during
lactation than during pregnancy. 33 % had similar risk perception
about medicine use in pregnancy and lactation.A survey of medicine use in postpartum women
n = 885
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use during pregnancy and medicine use information is
available for only up to 3 months postpartum. On the
other hand, cross-sectional surveys or small cohort studies
with little breastfeeding information do not represent the
diverse range of medicines used by women especially for
chronic illnesses such as depression, asthma, hyperten-
sion, thyroid problems, diabetes and epilepsy.
Although five studies indicated that maternal use of
certain medicines was associated with lower initiation
and/or duration of breastfeeding [33, 43, 47, 48, 51],
we cannot claim that all medicine use has a negative
impact on women’s breastfeeding practices. Moreover,
none of these studies received a full score in the
quality assessment, and are not free from bias. The
study by Ito et al. (1993) [51] might have attrition
bias as outcome data was only available for 62 % of
the women (125 of 203). Two other studies [33, 47]
were based on maternal use of different types of med-
icines, they were limited by their small sample size
(n = 246 and 88 respectively) and neither study ana-
lysed the impact of the specific drug/group according
to acute or chronic use or type of illness.
Strengths and limitations
The major strength of this review is the use of a
systematic approach. This is the first comprehensive
review focusing on extent of medicine use in postpar-
tum women and impact of maternal medicine use
postpartum on breastfeeding. The methodological
qualities of the included studies were also assessed
using quality appraisal tools.
The main limitation of this review is that we were
unable to conduct a meta-analysis because of the wide
differences in individual study design and outcome mea-
sures. Prescription and non-prescription medicine use
were not differentiated in the included studies, and this is
also a limitation. We did not include a complete search
for every therapeutic group and medicine as search terms.
Conclusion
The review of 18 studies found several studies including
maternal use of medicines for certain chronic diseases
(e.g. epilepsy, hyperthyroidism) demonstrated a negative
impact on initiation and /or duration of breastfeeding.
Further study is warranted as these studies were con-
ducted more than a decade ago. Moreover, we did not
get a complete picture why women discontinued breast-
feeding or did not start. Was this due to health profes-
sionals’ advice or other difficulties faced by women? This
review also reveals the need for a uniform reporting
system of medicine use in breastfeeding or postpartum
women using WHO’s ATC classification system. As the
existing register-based, large scale studies are limited
with data only up to 3 months postpartum and have no
breastfeeding information, more research is needed both
in developing and developed countries to establish base-
line information regarding medicine use in breastfeeding
women. Qualitative studies are also required to under-
stand how postpartum women make their decisions
about breastfeeding and medicine use and what influ-
ences their decision-making. Improved understanding
about maternal medicines and breastfeeding could lead
to improved evidence-based practice, and thus reduce
the dilemma of maternal medicines and breastfeeding.
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